Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
DBCAT003302Therapeutic category
A DrugBank category of 6 drugs. 6 of them are approved.
What you can answer from here — as of October 25, 2017
Which targets do Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account